1. Home
  2. DNTH vs UP Comparison

DNTH vs UP Comparison

Compare DNTH & UP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNTH
  • UP
  • Stock Information
  • Founded
  • DNTH 2015
  • UP 2013
  • Country
  • DNTH United States
  • UP United States
  • Employees
  • DNTH N/A
  • UP N/A
  • Industry
  • DNTH Biotechnology: Pharmaceutical Preparations
  • UP Aerospace
  • Sector
  • DNTH Health Care
  • UP Consumer Discretionary
  • Exchange
  • DNTH Nasdaq
  • UP Nasdaq
  • Market Cap
  • DNTH 657.0M
  • UP 597.8M
  • IPO Year
  • DNTH N/A
  • UP N/A
  • Fundamental
  • Price
  • DNTH $17.39
  • UP $1.31
  • Analyst Decision
  • DNTH Strong Buy
  • UP
  • Analyst Count
  • DNTH 8
  • UP 0
  • Target Price
  • DNTH $53.00
  • UP N/A
  • AVG Volume (30 Days)
  • DNTH 255.5K
  • UP 888.8K
  • Earning Date
  • DNTH 05-12-2025
  • UP 05-01-2025
  • Dividend Yield
  • DNTH N/A
  • UP N/A
  • EPS Growth
  • DNTH N/A
  • UP N/A
  • EPS
  • DNTH N/A
  • UP N/A
  • Revenue
  • DNTH $6,524,000.00
  • UP $772,533,000.00
  • Revenue This Year
  • DNTH N/A
  • UP $174.46
  • Revenue Next Year
  • DNTH N/A
  • UP N/A
  • P/E Ratio
  • DNTH N/A
  • UP N/A
  • Revenue Growth
  • DNTH 102.36
  • UP N/A
  • 52 Week Low
  • DNTH $13.37
  • UP $0.74
  • 52 Week High
  • DNTH $32.27
  • UP $4.59
  • Technical
  • Relative Strength Index (RSI)
  • DNTH 35.86
  • UP 47.36
  • Support Level
  • DNTH $17.40
  • UP $1.54
  • Resistance Level
  • DNTH $18.45
  • UP $1.72
  • Average True Range (ATR)
  • DNTH 1.21
  • UP 0.15
  • MACD
  • DNTH -0.22
  • UP -0.05
  • Stochastic Oscillator
  • DNTH 10.60
  • UP 21.55

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

About UP Wheels Up Experience Inc.

Wheels Up Experience Inc is a provider of on-demand private aviation in the United States. It is pioneering data and technology-driven solutions that connect consumers to safety-vetted and verified private aircraft. It connects private flyers to aircraft, and one another, through an open platform that enables life's most important experiences. Its offering is delivered through a mix of programmatic and charter options that strategically utilize its owned and leased aircraft fleet and an "asset-light" charter model to deliver a greater range of global travel alternatives. The company operates in a single operating and reportable segment, private aviation services. Geographically the company generates the majority of its revenue from the United States.

Share on Social Networks: